These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2139 related articles for article (PubMed ID: 16371630)

  • 21. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intensive glycemic control and cardiovascular disease: an update.
    Brown A; Reynolds LR; Bruemmer D
    Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
    ; Patel A; MacMahon S; Chalmers J; Neal B; Billot L; Woodward M; Marre M; Cooper M; Glasziou P; Grobbee D; Hamet P; Harrap S; Heller S; Liu L; Mancia G; Mogensen CE; Pan C; Poulter N; Rodgers A; Williams B; Bompoint S; de Galan BE; Joshi R; Travert F
    N Engl J Med; 2008 Jun; 358(24):2560-72. PubMed ID: 18539916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    Gaede P; Vedel P; Larsen N; Jensen GV; Parving HH; Pedersen O
    N Engl J Med; 2003 Jan; 348(5):383-93. PubMed ID: 12556541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1998 Apr; 128(7):517-23. PubMed ID: 9518395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
    ; Nathan DM; Genuth S; Lachin J; Cleary P; Crofford O; Davis M; Rand L; Siebert C
    N Engl J Med; 1993 Sep; 329(14):977-86. PubMed ID: 8366922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.
    Reaven PD; Emanuele NV; Wiitala WL; Bahn GD; Reda DJ; McCarren M; Duckworth WC; Hayward RA;
    N Engl J Med; 2019 Jun; 380(23):2215-2224. PubMed ID: 31167051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.
    Abraira C; Colwell J; Nuttall F; Sawin CT; Henderson W; Comstock JP; Emanuele NV; Levin SR; Pacold I; Lee HS
    Arch Intern Med; 1997 Jan; 157(2):181-8. PubMed ID: 9009975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study.
    Bebu I; Schade D; Braffett B; Kosiborod M; Lopes-Virella M; Soliman EZ; Herman WH; Bluemke DA; Wallia A; Orchard T; Lachin JM;
    Diabetes Care; 2020 Apr; 43(4):867-874. PubMed ID: 32001614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
    Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.
    Braffett BH; Dagogo-Jack S; Bebu I; Sivitz WI; Larkin M; Kolterman O; Lachin JM;
    Diabetes Care; 2019 Apr; 42(4):657-664. PubMed ID: 30728218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effect of diabetes and its treatment on cognitive function.
    ; Jacobson AM; Musen G; Ryan CM; Silvers N; Cleary P; Waberski B; Burwood A; Weinger K; Bayless M; Dahms W; Harth J
    N Engl J Med; 2007 May; 356(18):1842-52. PubMed ID: 17476010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
    Gubitosi-Klug R; Gao X; Pop-Busui R; de Boer IH; White N; Aiello LP; Miller R; Palmer J; Tamborlane W; Wallia A; Kosiborod M; Lachin JM; Bebu I;
    Diabetes Care; 2021 Jul; 44(7):1499-1505. PubMed ID: 33980605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.
    Gubitosi-Klug RA;
    Diabetes Care; 2014; 37(1):44-9. PubMed ID: 24356597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 diabetes, metabolic syndrome and cardiovascular risk.
    Chillarón JJ; Flores Le-Roux JA; Benaiges D; Pedro-Botet J
    Metabolism; 2014 Feb; 63(2):181-7. PubMed ID: 24274980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 107.